MREO NASDAQ
Mereo BioPharma Group plc
1W: +2.6%
1M: +42.1%
3M: +20.0%
YTD: -25.6%
1Y: -81.5%
3Y: -71.9%
5Y: -84.2%
$0.38
+0.01 (+3.52%)
Weekly Expected Move ±14.3%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Balance Sheet Trends
Total Assets
$46M
-39.9% ▼
5Y CAGR: -11.8%
Total Liabilities
$5M
-67.6% ▼
5Y CAGR: -45.8%
Shareholders Equity
$41M
-32.9% ▼
Cash & Investments
$41M
-41.3% ▼
5Y CAGR: +5.0%
Total Debt
$202K
-96.9% ▼
5Y CAGR: -61.7%
Net Debt
-$41M
+35.6% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $127M | $68M | $57M | $70M | $41M |
| Short-Term Investments | $769K | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $128M | $68M | $57M | $70M | $41M |
| Net Receivables | $0 | $0 | $4M | $3M | $1M |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $3M | $3M | $2M | $507K | $3M |
| Total Current Assets | $134M | $75M | $64M | $75M | $45M |
| Property, Plant & Equip. | $3M | $2M | $2M | $984K | $381K |
| Goodwill & Intangibles | $33M | $0 | $1M | $643K | $516K |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $1 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $37M | $2M | $3M | $2M | $897K |
| Total Assets | $171M | $77M | $66M | $76M | $46M |
| — Liabilities — | |||||
| Accounts Payable | $3M | $3M | $2M | $2M | $1M |
| Short-Term Debt | $0 | $13M | $0 | $6M | $202K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $8M | $1M | $2M | -$413K | $3M |
| Total Current Liabilities | $17M | $24M | $9M | $14M | $4M |
| Long-Term Debt | $19M | $0 | $4M | $0 | $0 |
| Other Non-Current Liab. | $13M | $157K | $1M | $1M | $699K |
| Total Non-Current Liabilities | $35M | $2M | $6M | $2M | $699K |
| Total Liabilities | $52M | $26M | $16M | $15M | $5M |
| — Equity — | |||||
| Common Stock | $2M | $2M | $3M | $3M | $3M |
| Retained Earnings | -$402M | -$405M | -$420M | -$463M | -$501M |
| Accumulated OCI | $184M | -$22M | -$17M | -$19M | -$11M |
| Total Stockholders Equity | $119M | $51M | $51M | $61M | $41M |
| Total Liabilities & Equity | $171M | $77M | $66M | $76M | $46M |
| — Key Metrics — | |||||
| Total Debt | $23M | $15M | $6M | $6M | $202K |
| Net Debt | -$104M | -$53M | -$51M | -$63M | -$41M |
| Total Investments | $769K | $0 | $0 | $0 | $0 |